[Experimental study of xenogeneic heart valve material]

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Vascular Biology

Context:

• Tissue-engineered heart valves aim to overcome limitations of current prostheses.
• Pre-endothelialization is a strategy to improve biocompatibility and reduce thrombogenicity.
• Developing novel xenogeneic materials is crucial for advanced valve scaffolds.

Purpose:

• To evaluate the efficacy of pre-endothelialization using cultured human umbilical vein endothelial cells (hUVECs) for improving tissue-engineered valve performance.
• To develop and assess a new xenogeneic bioprosthesis valve material.
• To optimize treatment protocols for porcine aortic valves to support endothelial cell growth.

Summary:

• Porcine aortic valves were treated with glutaraldehyde (GA), epoxychloropropane (EC), L-glutamic acid (L-GA), and cellular extraction (CE) in various combinations.
• Group 4 (EC + L-GA + CE) demonstrated superior hUVEC adhesion, proliferation, and complete surface coverage compared to other groups.
• hUVECs in Group 4 exhibited a 3D arrangement, indicating potential for resisting hemodynamic forces.

Impact:

• The optimized treatment protocol (EC + L-GA + CE) creates an ideal scaffold for hUVECs, enhancing xenogeneic valve material performance.
• Cultured hUVECs show promise as a source for seed cells in regenerative medicine applications.
• Compact endothelialization of xenogeneic scaffolds offers potential for robust, functional bioprosthetic valves resistant to cardiac pressures.